Security
Xtant Medical Holdings, Inc. Common Stock · BONE
BONEOTCCommon stockHistorical · closed Oct 19, 2015CIK 1453593Updated Oct 6, 2026
Name history
Bacterin International Holdings, Inc. · through Aug 3, 2015K KITZ INC · through May 21, 2010
Current security for this SEC filerXTNT · NYSE_AMERICAN
BONE price & chart
Historical security
This listing closed Oct 19, 2015. Live provider charts are shown only for current listings.
Current security: XTNT
About the company
We are a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Our products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 106,321,000Source | 98,882,000Source | 79,667,000Source | 103,479,000Source | 95,578,000Source | 78,000,000Source | 95,833,000Source | 93,931,000Source | 94,145,000Source | 93,837,000Source | 92,612,000Source | 60,229,000Source |
| Property, Plant and Equipment, NetUSD | 10,009,000Source | 10,284,000Source | 5,542,000Source | 10,447,000Source | 8,837,000Source | 5,854,000Source | 10,726,000Source | 8,867,000Source | 6,202,000Source | 10,131,000Source | 8,692,000Source | 5,785,000Source |
| GoodwillUSD | 7,302,000Source | 7,302,000Source | 6,074,000Source | 7,302,000Source | 7,302,000Source | 6,074,000Source | 7,302,000Source | 7,302,000Source | 6,074,000Source | 7,302,000Source | 7,302,000Source | 3,205,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 7,060,000Source | 8,788,000Source | 252,000Source | 7,492,000Source | 9,220,000Source | 275,000Source | 7,924,000Source | 9,652,000Source | 299,000Source | 8,356,000Source | 10,085,000Source | 344,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 10,400,000Source | 6,596,000Source | 9,870,000Source | 6,923,000Source | 5,379,000Source | 12,137,000Source | 5,032,000Source | 4,547,000Source | 17,053,000Source | 6,199,000Source | 5,715,000Source | 20,298,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 25,517,000Source | 20,545,000Source | 19,416,000Source | 26,951,000Source | 21,187,000Source | 17,179,000Source | 23,476,000Source | 21,484,000Source | 17,803,000Source | 20,660,000Source | 20,731,000Source | 10,853,000Source |
| Inventory, NetUSD | 40,714,000Source | 41,886,000Source | 33,287,000Source | 40,135,000Source | 40,507,000Source | 31,881,000Source | 38,812,000Source | 38,724,000Source | 30,263,000Source | 38,634,000Source | 36,885,000Source | 17,285,000Source |
| Assets, CurrentUSD | 78,330,000Source | 71,410,000Source | 64,777,000Source | 75,589,000Source | 68,972,000Source | 62,621,000Source | 69,144,000Source | 66,541,000Source | 78,245,000Source | 67,116,000Source | 64,869,000Source | 49,318,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,458,000Source | 1,893,000Source | 1,857,000Source | 1,466,000Source | 1,800,000Source | 1,404,000Source | 1,421,000Source | 1,709,000Source | 2,389,000Source | 1,601,000Source | 1,330,000Source | 673,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,619,000Source | 995,000Source | 2,894,000Source | 2,634,000Source | 1,117,000Source | 3,045,000Source | 736,000Source | 1,437,000Source | 3,192,000Source | 829,000Source | 1,523,000Source | 1,380,000Source |
| Other Assets, NoncurrentUSD | 1,000Source | 103,000Source | 128,000Source | 15,000Source | 130,000Source | 131,000Source | 1,000Source | 132,000Source | 133,000Source | 103,000Source | 141,000Source | 197,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 55,938,000Source | 53,157,000Source | 39,652,000Source | 54,977,000Source | 50,573,000Source | 29,401,000Source | 51,956,000Source | 46,251,000Source | 43,192,000Source | 50,874,000Source | 41,263,000Source | 26,058,000Source |
| Stockholders’ equity: | ||||||||||||
| Additional Paid in CapitalUSD | 304,787,000Source | 301,966,000Source | 307,004,000Source | 304,201,000Source | 296,451,000Source | 306,175,000Source | 303,487,000Source | 295,223,000Source | 305,439,000Source | 302,738,000Source | 294,330,000Source | 277,841,000Source |
| Retained Earnings (Accumulated Deficit)USD | -254,543,000Source | -256,295,000Source | -266,988,000Source | -255,851,000Source | -251,271,000Source | -257,575,000Source | -259,401,000Source | -247,410,000Source | -254,486,000Source | -259,459,000Source | -243,010,000Source | -243,670,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 139,000Source | 54,000Source | -1,000Source | 152,000Source | -175,000Source | -1,000Source | -209,000Source | -133,000Source | — | -316,000Source | 29,000Source | — |
| Stockholders' Equity Attributable to ParentUSD | 50,383,000Source | 45,725,000Source | 40,015,000Source | 48,502,000Source | 45,005,000Source | 48,599,000Source | 43,877,000Source | 47,680,000Source | 50,953,000Source | 42,963,000Source | 51,349,000Source | 34,171,000Source |
| Liabilities and EquityUSD | 106,321,000Source | 98,882,000Source | 79,667,000Source | 103,479,000Source | 95,578,000Source | 78,000,000Source | 95,833,000Source | 93,931,000Source | 94,145,000Source | 93,837,000Source | 92,612,000Source | 60,229,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 35,503,000Source | 33,669,000Source | 29,963,000Source | 30,600,000Source | 28,311,000Source | 18,773,000Source | 29,581,000Source | 28,442,000Source | 29,484,000Source | 28,581,000Source | 22,990,000Source | 15,218,000Source |
| Operating Lease, Liability, CurrentUSD | 760,000Source | 795,000Source | 594,000Source | 693,000Source | 794,000Source | 617,000Source | 646,000Source | 853,000Source | 622,000Source | 703,000Source | 830,000Source | 458,000Source |
| Accounts Payable, CurrentUSD | 6,856,000Source | 8,298,000Source | 6,154,000Source | 7,223,000Source | 6,875,000Source | 5,485,000Source | 7,121,000Source | 7,378,000Source | 3,844,000Source | 7,918,000Source | 7,054,000Source | 3,490,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,949,000Source | 247,000Source | 2,397,000Source | 2,015,000Source | 376,000Source | 2,525,000Source | 121,000Source | 644,000Source | 2,665,000Source | 166,000Source | 759,000Source | 972,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 5,000Source | 42,000Source | 21,000Source | — |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 11,535,000Source | 8,871,000Source | 7,481,000Source | 10,626,000Source | 8,676,000Source | 8,475,000Source | 10,492,000Source | 9,875,000Source | 10,626,000Source | 7,771,000Source | 10,419,000Source | 5,496,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 17,404,000Source | 19,138,000Source | 7,287,000Source | 22,278,000Source | 21,770,000Source | 8,095,000Source | 22,167,000Source | 16,826,000Source | 11,026,000Source | 22,038,000Source | 17,167,000Source | 9,687,000Source |
| Long-term Debt, Current MaturitiesUSD | — | 2,750,000Source | 3,720,000Source | — | — | 3,720,000Source | — | — | 3,500,000Source | — | — | 2,333,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 17,404,000Source | 19,138,000Source | 7,287,000Source | 22,278,000Source | 21,770,000Source | 8,095,000Source | 22,167,000Source | 16,826,000Source | 11,026,000Source | 22,038,000Source | 17,167,000Source | 9,687,000Source |
| Other Liabilities, Noncurrent | — | —Source | —Source | — | —Source | —Source | — | —Source | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 534,000Source | 1,074,000Source | 5,223,000Source | 4,224,000Source | 3,174,000Source | 1,292,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 600,000Source | 1,100,000Source | — | — | 746,000Source | 758,000Source | 2,892,000Source | 4,117,000Source | 2,739,000Source | 2,464,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -444,000Source | 3,114,000Source | 591,000Source | 755,000Source | 8,736,000Source | 3,941,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 1,611,000Source | 535,000Source | 1,999,000Source | 2,494,000Source | 1,886,000Source | 1,152,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 1,641,000Source | -890,000Source | -3,117,000Source | 1,033,000Source | 2,980,000Source | 875,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -38,000Source | 21,000Source | -1,901,000Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -2,114,000Source | 1,278,000Source | 12,546,000Source | -11,896,000Source | -9,515,000Source | -5,341,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | — | 4,503,000Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 10,220,000Source | -1,143,000Source | 7,899,000Source | -3,730,000Source | -24,784,000Source | -1,559,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 194,000Source | 1,191,000Source | 2,382,000Source | 4,113,000Source | 1,456,000Source | 1,764,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -13,275,000Source | -919,000Source | -9,570,000Source | 16,073,000Source | 19,691,000Source | 9,020,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | 2,841,000Source | — | 8,000,000Source | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -5,171,000Source | -786,000Source | 11,107,000Source | 298,000Source | -14,584,000Source | 2,120,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 10,641,000Source | 7,086,000Source | 10,217,000Source | 7,037,000Source | 12,157,000Source | 5,435,000Source | 17,328,000Source | 6,221,000Source | 5,923,000Source | 20,507,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 470,000Source | 882,000Source | 3,134,000Source | 3,638,000Source | 2,552,000Source | 1,454,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 121,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 400,000Source | 400,000Source | 0Source | 500,000Source | 0Source | 400,000Source | 1,600,000Source | 1,700,000Source | 1,400,000Source | 100,000Source |
| DepreciationUSD | — | — | 700,000Source | 700,000Source | 500,000Source | 800,000Source | 500,000Source | 600,000Source | 3,600,000Source | 2,500,000Source | 1,800,000Source | 1,200,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | — | — | -56,000Source | 27,000Source | 23,000Source | 178,000Source | -1,000Source | 24,000Source | -60,000Source | 5,000Source | 265,000Source | — |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | 14,000Source | 37,000Source | -251,000Source | 264,000Source | 115,000Source | 93,000Source |
| General and Administrative ExpenseUSD | — | — | 7,071,000Source | 7,493,000Source | 6,436,000Source | 7,478,000Source | 6,273,000Source | 7,533,000Source | 29,375,000Source | 28,691,000Source | 25,850,000Source | 15,462,000Source |
| GoodwillUSD | — | — | 7,302,000Source | 7,302,000Source | 6,074,000Source | 7,302,000Source | 6,074,000Source | 7,302,000Source | 6,074,000Source | 7,302,000Source | 7,302,000Source | 3,205,000Source |
| Income Tax Expense (Benefit)USD | — | — | 257,000Source | 62,000Source | 73,000Source | 255,000Source | 27,000Source | -25,000Source | 2,028,000Source | 187,000Source | -1,697,000Source | 69,000Source |
| InterestExpenseNonoperatingUSD | — | — | 904,000Source | 1,199,000Source | 542,000Source | 1,004,000Source | 599,000Source | 1,045,000Source | 3,671,000Source | 4,160,000Source | — | — |
| Inventory Write-downUSD | — | — | — | — | — | — | 922,000Source | 541,000Source | 3,669,000Source | 485,000Source | 357,000Source | 1,812,000Source |
| Investment Income, InterestUSD | — | — | — | — | 1,000Source | — | 219,000Source | — | 94,000Source | — | 149,000Source | 31,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 1,308,000Source | -5,024,000Source | -9,413,000Source | 3,550,000Source | -3,089,000Source | 58,000Source | 4,973,000Source | -16,449,000Source | 660,000Source | -8,485,000Source |
| Nonoperating Income (Expense)USD | — | — | -976,000Source | -1,185,000Source | -171,000Source | -819,000Source | -139,000Source | -1,030,000Source | -283,000Source | -4,188,000Source | 9,121,000Source | -1,661,000Source |
| Operating ExpensesUSD | — | — | 19,451,000Source | 20,084,000Source | 22,499,000Source | 19,660,000Source | 14,894,000Source | 19,180,000Source | 76,989,000Source | 80,290,000Source | 65,625,000Source | 38,892,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 1,200,000Source | 900,000Source | 700,000Source | 600,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -16,000Source | -13,000Source | 347,000Source | 7,000Source | 242,000Source | -9,000Source | 73,000Source | -33,000Source | — | — |
| Payments to Acquire InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | 17,000,000Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | — | 14,011,000Source | 9,311,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | 5,000,000Source | 4,761,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | 13,000Source | — | — |
| Goodwill, Impairment Loss | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 33,255,000Source | 27,937,000Source | 23,031,000Source | 35,411,000Source | 20,884,000Source | 32,904,000Source | 133,927,000Source | 117,267,000Source | 91,303,000Source | 57,969,000Source |
| Cost of RevenueUSD | — | — | 11,263,000Source | 11,630,000Source | 9,701,000Source | 11,127,000Source | 8,913,000Source | 12,661,000Source | 49,654,000Source | 49,051,000Source | 35,836,000Source | 25,832,000Source |
| Operating Income (Loss)USD | — | — | 2,541,000Source | -3,777,000Source | -9,169,000Source | 4,624,000Source | -2,923,000Source | 1,063,000Source | 7,284,000Source | -12,074,000Source | -10,158,000Source | -6,755,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -16,000Source | -13,000Source | 347,000Source | 7,000Source | 242,000Source | -9,000Source | 73,000Source | -33,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 1,565,000Source | -4,962,000Source | -9,340,000Source | 3,805,000Source | -3,062,000Source | 33,000Source | 7,001,000Source | -16,262,000Source | -1,037,000Source | -8,416,000Source |
| Income Tax Expense (Benefit)USD | — | — | 257,000Source | 62,000Source | 73,000Source | 255,000Source | 27,000Source | -25,000Source | 2,028,000Source | 187,000Source | -1,697,000Source | 69,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 1,308,000Source | -5,024,000Source | -9,413,000Source | 3,550,000Source | -3,089,000Source | 58,000Source | 4,973,000Source | -16,449,000Source | 660,000Source | -8,485,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.01Source | -0.04Source | -0.07Source | 0.03Source | -0.02Source | 0Source | 0.04Source | -0.12Source | 0.01Source | -0.09Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.01Source | -0.04Source | -0.07Source | 0.02Source | -0.02Source | 0Source | 0.03Source | -0.12Source | 0.01Source | -0.09Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 139,712,969Source | 135,100,233Source | 140,258,667Source | 139,310,589Source | 140,058,787Source | 139,068,831Source | 139,531,791Source | 133,665,075Source | 119,093,687Source | 94,085,197Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 150,377,234Source | 135,100,233Source | 140,258,667Source | 148,574,242Source | 140,058,787Source | 143,335,114Source | 150,042,556Source | 133,665,075Source | 126,793,318Source | 94,085,197Source |
| Interest Expense (non-operating)USD | — | — | 904,000Source | 1,199,000Source | 542,000Source | 1,004,000Source | 599,000Source | 1,045,000Source | 3,671,000Source | 4,160,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 400,000Source | 400,000Source | 0Source | 500,000Source | 0Source | 400,000Source | 1,600,000Source | 1,700,000Source | 1,400,000Source | 100,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 2,066,000Source | 166,000Source | 204,000Source | — |
| General and Administrative ExpenseUSD | — | — | 7,071,000Source | 7,493,000Source | 6,436,000Source | 7,478,000Source | 6,273,000Source | 7,533,000Source | 29,375,000Source | 28,691,000Source | 25,850,000Source | 15,462,000Source |
| Gross ProfitUSD | — | — | 21,992,000Source | 16,307,000Source | 13,330,000Source | 24,284,000Source | 11,971,000Source | 20,243,000Source | 84,273,000Source | 68,216,000Source | 55,467,000Source | 32,137,000Source |
| Interest ExpenseUSD | — | — | — | — | 542,000Source | 1,004,000Source | 599,000Source | 1,045,000Source | 3,671,000Source | 4,160,000Source | 2,938,000Source | 1,692,000Source |
| Investment Income, InterestUSD | — | — | — | — | 1,000Source | — | 219,000Source | — | 94,000Source | — | 149,000Source | 31,000Source |
| Nonoperating Income (Expense)USD | — | — | -976,000Source | -1,185,000Source | -171,000Source | -819,000Source | -139,000Source | -1,030,000Source | -283,000Source | -4,188,000Source | 9,121,000Source | -1,661,000Source |
| Operating ExpensesUSD | — | — | 19,451,000Source | 20,084,000Source | 22,499,000Source | 19,660,000Source | 14,894,000Source | 19,180,000Source | 76,989,000Source | 80,290,000Source | 65,625,000Source | 38,892,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 1,200,000Source | 900,000Source | 700,000Source | 600,000Source |
| Other ExpensesUSD | — | — | — | — | — | — | — | — | — | 33,000Source | 49,000Source | — |
| Other IncomeUSD | — | — | — | — | — | — | — | — | — | — | — | 11,000Source |
| Research and Development ExpenseUSD | — | — | 634,000Source | 701,000Source | 695,000Source | 566,000Source | 435,000Source | 443,000Source | 2,102,000Source | 2,385,000Source | 1,336,000Source | 915,000Source |
| Selling and Marketing ExpenseUSD | — | — | 11,746,000Source | 11,890,000Source | 10,368,000Source | 11,616,000Source | 8,186,000Source | 11,204,000Source | 45,512,000Source | 49,214,000Source | 38,439,000Source | 22,515,000Source |
| Goodwill, Impairment Loss | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
Offerings
Registration 333-287192
Filing attachments
ex99-1.htm · 8-K · 2026-08-11
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Xtant Medical Reports Second Quarter 2026 Financial Results Launched Trivium™ Shaped, an extension of its Trivium line of premium, next-generation demineralized bone matrix allograft for bone grafting procedures Company to host investor conference call and webcast today, August 11th, at 8:30am ET BELGRADE, Mont., August 11, 2026 - Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for sp…
Read attachment ↗ex99-1.htm · 8-K · 2026-05-13
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Xtant Medical Reports First Quarter 2026 Financial Results Raises full-year 2026 revenue guidance to a range of $101-$105 million Significantly strengthens balance sheet Enters into exclusive U.S. distribution agreement for Dilon Technologies’ HEMOBLAST® Bellows product for high-performance hemostasis; hires Dilon’s U.S. sales team BELGRADE, Mont., May 13, 2026 - Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company fo…
Read attachment ↗ex99-1.htm · 8-K · 2026-04-13
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon’s HEMOBLAST® Bellows Product Xtant has hired Dilon’s U.S. sales team to assist in selling the HEMOBLAST® Bellows product and penetrating the estimated $2.0 billion global addressable market for hemostatic products BELGRADE, Mont., and NEWPORT NEWS, VA., April 13, 2026 - Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focus…
Read attachment ↗ex4-1.htm · 10-K · 2026-03-31
Exhibit 4.1 XTANT MEDICAL HOLDINGS, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Xtant Medical Holdings, Inc., a Delaware corporation (Xtant, we, us and our), has only one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock, par value $0.000001 (common stock). The following description summarizes the material terms and provisions of our common stock and does not purpor…
Read attachment ↗ex99-1.htm · 8-K · 2026-03-31
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results Full year 2025 revenue totals $133.9 million, an increase of 14% year-over-year Xtant delivers positive net income, adjusted EBITDA and operating cash flow Total cash of $17.3 million as of December 31, 2025 with an additional $10.5 million received subsequent to year end related to divestiture BELGRADE, Mont., March 31, 2026 - Xtant Medical Holdings, Inc. (NYSE American: …
Read attachment ↗ex99-1.htm · 8-K · 2025-12-03
EX-99.1 4 ex99-1.htm EX-99.1 Exhibit 99.1 XTANT MEDICAL HOLDINGS, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION The following unaudited pro forma condensed consolidated financial information was derived from the historical consolidated financial statements of Xtant Medical Holdings, Inc. (the “Company”) as described in more detail below and is being presented to give effect to: the sale of certain assets relating to the Company’s Coflex and CoFix products (the…
Read attachment ↗